Lupin ties up with Scope Opthalmics to market eyecare products in Mexico

Drug maker Lupin has signed a distribution agreement with Ireland-based Scope Ophthalmics to market the Optase range of eye care products in Mexico, aimed at treating conditions like dry eyes, blepharitis, and meibomian gland dysfunction. This deal enhances Lupin’s ophthalmology portfolio while expanding Scope’s presence in Latin America, emphasizing their commitment to improving vision care.